1 Min Read
Jan 3 (Reuters) - INVENTIVA SA:
* ENROLLMENT OF FIRST PATIENT INTO ITS ODIPARCIL PHASE IIA TRIAL (IMPROVES) FOR MPS VI
* RESULTS EXPECTED DURING H1 2019 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.